Patterson Companies Past Earnings Performance
Past criteria checks 1/6
Patterson Companies has been growing earnings at an average annual rate of 35.1%, while the Healthcare industry saw earnings growing at 10.4% annually. Revenues have been growing at an average rate of 4.4% per year. Patterson Companies's return on equity is 19.9%, and it has net margins of 3%.
Key information
35.1%
Earnings growth rate
34.8%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 4.4% |
| Return on equity | 19.9% |
| Net Margin | 3.0% |
| Last Earnings Update | 27 Jan 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Patterson Companies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 27 Jan 24 | 6,567 | 194 | 1,118 | 0 |
| 28 Oct 23 | 6,552 | 200 | 1,104 | 0 |
| 29 Jul 23 | 6,525 | 214 | 1,091 | 0 |
| 29 Apr 23 | 6,471 | 208 | 1,089 | 0 |
| 28 Jan 23 | 6,389 | 196 | 1,079 | 0 |
| 29 Oct 22 | 6,385 | 200 | 1,090 | 0 |
| 30 Jul 22 | 6,408 | 194 | 1,088 | 0 |
| 30 Apr 22 | 6,499 | 203 | 1,093 | 0 |
| 29 Jan 22 | 6,422 | 168 | 1,082 | 0 |
| 30 Oct 21 | 6,377 | 160 | 1,073 | 0 |
| 31 Jul 21 | 6,281 | 166 | 1,056 | 0 |
| 24 Apr 21 | 5,912 | 156 | 989 | 0 |
| 23 Jan 21 | 5,637 | -481 | 957 | 0 |
| 24 Oct 20 | 5,542 | -507 | 957 | 0 |
| 25 Jul 20 | 5,407 | -594 | 971 | 0 |
| 25 Apr 20 | 5,490 | -588 | 1,011 | 0 |
| 25 Jan 20 | 5,640 | 48 | 1,016 | 0 |
| 26 Oct 19 | 5,581 | 56 | 1,029 | 0 |
| 27 Jul 19 | 5,567 | 118 | 1,021 | 0 |
| 27 Apr 19 | 5,575 | 84 | 1,045 | 0 |
| 26 Jan 19 | 5,538 | 77 | 1,030 | 0 |
| 27 Oct 18 | 5,517 | 154 | 995 | 0 |
| 28 Jul 18 | 5,498 | 166 | 987 | 0 |
| 28 Apr 18 | 5,466 | 201 | 979 | 0 |
| 27 Jan 18 | 5,510 | 241 | 970 | 0 |
| 28 Oct 17 | 5,532 | 160 | 972 | 0 |
| 29 Jul 17 | 5,565 | 166 | 968 | 0 |
| 29 Apr 17 | 5,593 | 174 | 977 | 0 |
| 28 Jan 17 | 5,602 | 178 | 992 | 0 |
| 29 Oct 16 | 5,605 | 207 | 989 | 0 |
| 30 Jul 16 | 5,576 | 204 | 996 | 0 |
| 30 Apr 16 | 5,387 | 186 | 961 | 0 |
| 30 Jan 16 | 4,968 | 174 | 907 | 0 |
| 31 Oct 15 | 4,526 | 163 | 848 | 0 |
| 01 Aug 15 | 4,115 | 162 | 788 | 0 |
| 25 Apr 15 | 3,911 | 180 | 756 | 0 |
| 24 Jan 15 | 3,978 | 182 | 780 | 0 |
| 25 Oct 14 | 4,102 | 193 | 810 | 0 |
| 26 Jul 14 | 4,123 | 193 | 837 | 0 |
| 26 Apr 14 | 3,585 | 171 | 725 | 0 |
| 25 Jan 14 | 3,927 | 209 | 849 | 0 |
| 26 Oct 13 | 3,760 | 205 | 845 | 0 |
| 27 Jul 13 | 3,628 | 209 | 833 | 0 |
Quality Earnings: PD2 has a high level of non-cash earnings.
Growing Profit Margin: PD2's current net profit margins (3%) are lower than last year (3.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PD2's earnings have grown significantly by 35.1% per year over the past 5 years.
Accelerating Growth: PD2's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PD2 had negative earnings growth (-1.3%) over the past year, making it difficult to compare to the Healthcare industry average (-2.5%).
Return on Equity
High ROE: PD2's Return on Equity (19.9%) is considered low.